InvestorsHub Logo
Followers 140
Posts 11663
Boards Moderated 0
Alias Born 03/15/2011

Re: nuke661 post# 243719

Wednesday, 11/25/2015 4:48:44 PM

Wednesday, November 25, 2015 4:48:44 PM

Post# of 346050
nuke, exactly.

I also considered SK was making assumptions when he said it. I thought the major input to the assumptions back then would be the information they had from PII and expected enrolment curves for PIII. The PII data is a fixed item and the only major variable that I can see is how actual enrolments coincided with the expectations they had back then.



That is why I kept posting that every update confirming what they expected (and what they must have called 'ON TRACK') was valuable because at every update these apparently 'identical' statements became more substantiated for them.

They were each time based on more recent data and each time narrowing the window for error. Hence CEO King's last update in relation to as well End of Enrolment in DEC 2015 and unblinding before year end 2016, actually DEC 2016 at the last, are tremendously valuable.

The BIGGEST risk was :
A) not being able to open the intended SUNRISE centres (risk gone)
B) not being able to enrol the needed patients (risk mainly gone)
C) not being able to finance till approval (risk gone)

Peregrine Pharmaceuticals the Microsoft of Biotechnology! All In My Opinion. I am not advising anything, nor accusing anyone.

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent CDMO News